Market Potential

Aesthetics
Aesthetics
Ortho/Pain/Rehab
Ortho/Pain/Rehab
Total Market Size
Total Market Size
TAM
$6.25B
$21.4B
$27.6B
SAM
$800M
$1.7B
$2.5B
SOM
$96M
$217M
$313M*

*Based on 2030 Revenue Projection

The Total Addressable Market (TAM) represents the total revenue potential across the Aesthetics and Orthopedic, Pain and Rehabilitation markets that AdiFlo could achieve if it held 100% of the market share.
Serviceable Addressable Market (SAM) reflects the current revenue potential in TAM AdiFlo can realistically serve based on its existing products within the Aesthetics and Orthopedic, Pain and Rehabilitation markets.
Serviceable Obtainable Market (SOM) represents the revenue portion of SAM that we can realistically achieve based on sale capacity and market traction within the Aesthetics and Orthopedic, Pain and Rehabilitation markets.

Market Strategy

Adiflo devices have been designed to integrate directly into existing regenerative medicine and adipose processing workflows through a scalable system built for clinical efficiency and repeat procedural use.

Initial Targets

Our commercialization strategy initially targets plastic surgery clinics, regenerative medicine centers, and high-volume surgical facilities seeking standardized, high-throughput adipose tissue processing.

Recurring-Use Model

The system uses replaceable EMD and RefineX processing components that clinics routinely purchase for repeated procedures. This approach supports sterility, consistency, and long-term operational scalability while lowering adoption barriers through integration with existing clinical infrastructure.

Long-Term Growth

As more clinics adopt the Sayenza and Adiflo platform, continued use of replacement components and partnerships with clinical organizations will help drive long-term growth across regenerative medicine applications.

Growth Flywheel

Platform Adoption

Clinics deploy Sayenza

Repeat Purchases

EMD + RefineX refills

Partnerships

Clinical organizations

Market Expansion

New regen. applications

Drop-In Integration

By combining the core Sayenza platform with replaceable processing components, the system lowers adoption barriers through integration with existing clinical infrastructure.

Reproducible Performance

The system supports reproducible performance, reduced workflow disruption, and scalable clinical adoption across regenerative medicine workflows.